Michael Heathman

Pharmacokinetics of Teriparatide (rhPTH[1–34]) and Calcium Pharmacodynamics in Postmenopausal Women with Osteoporosis

Julie Satterwhite, Michael Heathman, Paul D. Miller et al. · Calcified Tissue International · 2010 · 107 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Clinical Pharmacokinetics of Dulaglutide in Patients with Type 2 Diabetes: Analyses of Data from Clinical Trials

Jeanne S. Geiser, Michael Heathman, Xuewei Cui et al. · Clinical Pharmacokinetics · 2015 · 101 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +13

Dose‐finding results in an adaptive, seamless, randomized trial of once‐weekly dulaglutide combined with metformin in type 2 diabetes patients (<scp>AWARD</scp>‐5)

Zachary Skrivanek, Brenda Gaydos, Jenny Y. Chien et al. · Diabetes Obesity and Metabolism · 2014 · 72 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Effect of age on the pharmacokinetics of duloxetine in women

Michael Skinner, Han‐Yi Kuan, Andrej Skerjanec et al. · British Journal of Clinical Pharmacology · 2003 · 70 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Exposure-Response Analyses of Ramucirumab from Two Randomized, Phase III Trials of Second-line Treatment for Advanced Gastric or Gastroesophageal Junction Cancer

Josep Tabernero, Atsushi Ohtsu, Kei Muro et al. · Molecular Cancer Therapeutics · 2017 · 48 citations · Full text

Pharmacy, Oncology, Pharmacology +17